Rating Change
Canaccord Genuity analysts initiated coverage on ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) with a Hold rating on July 17, 2026.
new coverageNASDAQ:ANIP
Canaccord Genuity Initiates Coverage on ANI Pharmaceuticals, Inc. (ANIP) with Hold
Rating Change Canaccord Genuity analysts initiated coverage on ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) with a Hold rating on July 17, 2026. Market Context ANI Pharmaceuticals, Inc.
Market Context
ANI Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $79.20 with a market capitalization of $1.7B. The stock has gained 18.9% over the past 52 weeks.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ANI Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ANI Pharmaceuticals, Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 17, 2026 | Canaccord Genuity | Hold | N/A |
| Jul 10, 2026 | Guggenheim | Buy | N/A |
| Jan 16, 2026 | Guggenheim | Buy | N/A |
| Dec 09, 2025 | Barclays | Overweight | N/A |
| Nov 10, 2025 | Guggenheim | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ANIP Stock Page
Frequently Asked Questions
What does a Hold rating mean for ANIP?
A Hold rating from Canaccord Genuity reflects the analyst's outlook on ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ANIP forecast page.